Alzheimer's Disease

FDA approves Alzheimer's drug for mild, early-stage disease

U.S. Food and Drug Administration (FDA)

Amid scrutiny FDA hits slowdown on accelerated drug approvals

robotic dog

Robotic pets offer companionship to seniors

Rep. Rosa DeLauro

How government funding bills are strengthening America’s health

Addressing the ‘Trust Factor’: South Carolina researchers tackle health disparities using genetics

CMS to adjust Medicare premiums in 2023 due to lower Aduhelm costs

54th Street Marketing Photo.jpg

Mergers & Acquisitions

Rensselaer, Mount Sinai partner on center to tackle uncured diseases

Change at the top for Biogen after Alzheimer's drug flops

UnitedHealthcare_i_i_i_i copy_i.png

UnitedHealthcare to limit Aduhelm access

money and pills

Medicare finalizes policy restricting Aduhelm coverage to clinical trial patients

Sponsored Content